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Immunoneutralization of maternal RCP results in a >90% decrease in the content and the incorporation 
of [2-Yfriboflavin into embryonic FAR as we11 as a percentage r distribution of both embryonic FMN 
and ribo~a~n. This is ~accompanied by any disce~ible changes in flavin distribution pattern in the mater- 
nal liver. Embryonic u-gtycerophosphate d hydrogenase and NADP~-cytochrome c reductase register sig- 
nificant decreases in activities in the RCP antiserum-treated rats, These alterations readily explain the arrest 
of foetal growth culminating in pregnancy termination in the antiserum-treated animals. 
Immunoneutralization RCP 
1. INTRODUCTION 
We have earlier provided evidence for the occur- 
rence and obligatory participation of a specific, 
high-affinity carrier protein, viz., riboflavin car- 
rier protein (RCP) in transplacental flavin 
transport in the pregnant rat. The functional im- 
portance of the rodent protein during gestation in 
terms of unremitting flavin supply and hence, 
uninterrupted foetal growth, was demonstrated by 
passive immunoneutralization of the endogeuous 
maternal RCP with specific antisera to either the 
homologous (11 or the heterologous [2] RCP. This 
precipitated acute foetal wastage and abrupt 
pregnancy termination. In attempts to delve into 
the intraembryonic events culminating in foetal 
death, we have shown that immunoneutralization 
of the carrier protein leads to drastic curtailment 
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Abbreviations: RCP, riboflavin carrier protein; a/s, an- 
tiserum; FAD, flavin adenine dinucleotide; FMN, flavin 
mononuc~eotide 
FAD Fetal wastage Flavin 
of [2-14C]riboflavin transport to the foetopIacenta1 
unit with consequent arrest of growth [3]. Confir- 
matory evidence for the essentiality of material 
RCP for foetal survival stems from experiments 
wherein active immunization of fertile female rats 
with the heterologous (chicken) RCP terminated 
their early pregnancies without any detrimental ef- 
fect on maternal growth, cyclicity, vitamin status 
and subsequent ability to conceive (41. In attempts 
to delineate the molecular processes that follow in- 
traembryonicaliy, we show that marked depletion 
of embryonic total flavin content, following im- 
munoneutralization of the maternal carrier pro- 
tein, sets in motion pronounced disturbances in the 
relative proportions of individual flavins, with 
changes in FAD being most significant, 
2. MATERIALS AND METHODS 
The sources of [2-14C]riboflavin and other 
reagents as well as monitoring of pregnancies of 
adult female rats have been described 131. The 
prep~ation and ch~acterization of rabbit a/s to 
purified chicken RCP and its administration to 
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rats on day 11 of pregnancy were as in [3]. All 
operations thereafter were carried out in diffused 
light. Aqueous tissue homogenates (20% w/v) 
were heated at 70°C for 3 min prior to quantifica- 
tion of the total radioactivity and total flavin con- 
tents in the extracts [3]. For the quantification of 
[2-14C]riboflavin associated with different flavins 
and to determine the basal level of endogenous 
tissue flavins, the heat-denatured extracts were 
clarified by centrifugation (1000 x g, 10 min at 
4”C), concentrated to a small volume and the 
flavin components therein were resolved by 
descending chromatography on Whatman no.3 
filter paper using n-butanol/acetic acid/water, 
12: 3 : 5, v/v/v, as the solvent system alongside 
known graded amounts of standard riboflavin, 
FMN and FAD (Sigma). The flavins separated on 
the air-dried chromatogram were identified by 
their fluorescence in UV light and individual 
flavins were either directly counted for radioactivi- 
ty by liquid scintillation spectrometry or eluted 
from the paper with distilled water at 60°C and 
quantified fluorimetrically [3]. The mitochondrial 
a-glycerophosphate dehydrogenase @GPD) activi- 
ty was determined spectrophotometrically using 
phenazine methosulphate (PMS) and dichloro- 
phenol indophenol (DCIP) as electron acceptors 
[5]. The foetal microsomal NADPH-cytochrome c 
reductase activity was also measured spectrophoto- 
metrically as in [6]. 
3. RESULTS 
Sharp curtailment of transplacental transport of 
[2-i4C]riboflavin administered to pregnant rats, as 
a consequence of immunoneutralization of mater- 
nal RCP, is revealed by an approx. 80% decrease 
in the labelled flavin uptake by the foetal tissue 
when compared to that from control animals 
treated with nonimmune rabbit serum (NRS); a 
similar pattern was observed when radioactivity 
was expressed either per foetus or unit fresh weight 
of the tissue (table 1). From the relative distribu- 
tion of radioactivity among individual flavins, it is 
evident that FAD represented the maximally 
labelled component which accounted for -50% of 
the total “C-labelled vitamin taken up by the con- 
trol foetus, the remainder being equally distributed 
between FMN and riboflavin. In contrast, there 
was a drastic decrease in radioactivity associated 
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with foetal FAD from the a/s treated animals 
which represented only 2-3% of the total radioac- 
tivity in control foetuses and 13% of total labelled 
flavins in those from the a/s treated mothers. 
However, relative decreases in labelled FMN and 
riboflavin were less marked. Radioactivity 
associated with FMN in control foetal tissue 
represented -7% of the total labelled flavins vis-a- 
vis 40% in a/s treated animals. Corresponding 
values for free riboflavin were 8 and 45070, respec- 
tively. In other words, labelled FMN plus 
riboflavin comprised a greater proportion of total 
radioactive flavins in foetuses from a/s treated 
animals compared with those from control 
animals, notwithstanding a steep decrease in 
[i4C]riboflavin transport to the foetuses in im- 
munoneutralized animals. Further, this altered 
pattern of relative redistribution of labelled 
vitamin among different flavins in a/s treated 
animals, was confined to the foetal tissue since, 
concurrently, there was no discernible change in 
flavin pattern in the maternal liver (not shown). 
Corresponding changes in the relative levels of 
individual and total flavin contents in the foetuses 
from the control and a/s treated animals as quan- 
tified spectrophotometrically are also depicted in 
table 1. It was found that a/s administration 
brought about -30% reduction in foetal weight 
which was accompanied by a 50% decrease in total 
flavin content. A comparison of the levels of in- 
dividual flavins in foetuses from the control vis-a- 
vis in those from a/s treated animals revealed that 
pronounced depletion in both the content and con- 
centration of FAD was the major alteration ac- 
companying RCP immunoneutralization. This was 
followed by an apparent but statistically non- 
significant increase in both FMN and riboflavin 
contents in the affected foetus. The selective 
nature of such a disturbance in flavin nucleotide 
levels in the foetal tissue is exemplified by the data 
of table 2, which shows that in the maternal iver, 
the flavin distribution pattern, including the con- 
tribution of FAD accounting for 80% of total 
flavins remained unperturbed on RCP a/s 
treatment. 
A drastic decrease in foetal flavin levels in 
general, and in FAD levels in particular in the RCP 
a/s treated animals, could be expected to reflect in 
depleted activities of some of the FAD-dependent 
foetal flavoenzymes. Two representatives of FAD- 
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Table 1 
Effect of immunoneutralization of maternal RCP in the pregnant rat on incorporation of [2-‘4C]riboflavin 
into and contents of ,different flavins in the foetal tissue 
Flavin 
Total 
FAD 
FMN 
Riboflavin 
Control foetus 
Radioactivity (cpm x 10W3) Flavin content (ng) 
per mg tissue per foetus per mg tissue per foetus 
0.320 + 0.012 40.9 +- 2.0 3.4 * 0.2 705 * 82 
0.173 + 0.006 22.1 + 0.8 2.4 f 0.5 470 f 131 
0.080 * 0.010 10.3 f 1.4 0.2 * 0.1 44f 15 
0.066 + 0.010 8.4 + 1.6 0.3 f 0.1 59 + 27 
RCP a/s-affected foetus 
Spec. 
radioactivity 
(cpming) 
0.058 
0.047 
0.234 
0.142 
Radioactivity (cpm x 10e3) Flavin content (ng) Spec. 
radioactivity 
per mg tissue per foetus per mg tissue per foetus (cpmjng) 
Total 0.073 + 0.01 6.9 2 1.0 2.6 f 0.1 327 * 52 0.021 
FAD 0.009 f 0.004 0.9 -+ 0.4 0.2 + 0.1 27k 17 0.033 
FMN 0.029 + 0.01 2.8 & 1.1 0.5 f 0.2 69+ 15 0.040 
Riboflavin 0.033 * 0.004 3.2 + 0.4 1.1 -t 0.6 131 + 67 0.024 
Pregnant rats (day 11) were injected either 0.5 ml NRS (control) or 0.5 ml RCP a/s and killed 24 h later. Total 
and individual flavin contents of clarified embryonic homogenates were estimated fluorimetrically. For the 
measurement of embryonic uptake and distribution of [2-‘4C]riboflavin, pregnant rats were injected the 
labelled vitamin (0.5 ,&i equivalent to 6 gg/animal) 1 h after antiserum treatment. Embryos were removed 
24 h later and analyzed chromatographically for radioactive flavins. Values repesent mean + SE (n = 5) 
dependent foetal enzymes, viz., the mitochondrial 
a-glycerophosphate dehydrogenase and the 
microsomal NADPH-cytochrome c-reductase have 
Table 2 
Effect of immunoneutralization of RCP on distribution 
of flavin coenzymes in maternal liver 
7lavin pg/g Liver 
Control RCP a/s 4. DISCUSSION 
FAD 20.6 + 2.0 19.5 + 1.8 
FMN 3.6 f 1.0 5.1 * 1.2 
Riboflavin 3.7 f 1.3 4.6 f 1.6 
Pregnant rats (day 11) were injected with either NRS or 
cRCP a/s (intraperitoneally) and killed 24 h later. Livers 
were analyzed for individual flavins by monitoring 
flavin fluorescence. Values are mean + SE (n = 5). 
Changes in contents of FAD, FMN and riboflavin in 
livers from the a/s treated group were not statistically 
significant (P > 0.25) 
been assessed in the control and RCP a/s affected 
foetal tissues at 24 h after a/s treatment to rats 
during day 12 of gestation (fig.1). It is clear that 
both the enzyme activities register a significant 
decrease in terms of both total and specific ac- 
tivities although the extents of inhibition observed 
were not commensurate with the corresponding 
depletion in FAD levels in the affected foetuses. 
It is clear that acute riboflavin deprivation 
culminating in foetal wastage in RCP a/s treated 
pregnant rats is attended by a selective but drastic 
disturbance in the labelled vitamin distribution 
among different foetal flavins with FAD exhibiting 
the most pronounced decrease. A comparison of 
specific radioactivities of different flavins in the 
normal and affected foetuses (table 1) reveals that 
the major consequence of acute flavin deficiency in 
the foetus is the pronounced inhibition of FAD 
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Fig. 1. Influence of RCP a/s on the embryonic activities 
of two FAD dependent flavoenzymes: I control; 
m RCP a/s treated. (A) Mitochondrial (Y- 
glycerophosphate dehydrogenase. The assay mixture 
(3.0 ml) contained 83.3 mM potassium phosphate 
buffer (pH 7.4), 33.3 mM KCl, 3 mM KCN, 3.3 mM 
MgC12, 1.8 mg BSA, 0.2 mM PMS, 0.26 mmol DCIP, 
0.04 M DLiy-glycerophosphate, and 0.5-1.0 mg 
mitochondrial protein. (B) Microsomal NADPH- 
cytochrome c reductase. The reaction mixture (3 ml) 
comprised 0.33 M potassium phosphate buffer (pH 7.6), 
50 mM cytochrome c, 42 mM NADPH and microsomal 
protein. Vertical bars represent SE (n = 5). 
elaboration [7]; that its biosynthesis is presumably 
affected is supported by the following: in the nor- 
mal foetus, FMN/riboflavin ratio is 1.6 and that 
of FMN/FAD is 5, showing that FMN--+FAD 
conversion is the rate-limiting step in FAD syn- 
thesis in the foetus. On the other hand, in the af- 
fected foetus, FMN/riboflavin ratio is comparable 
to that in the control foetus, while the FMN/FAD 
value (1.2) shows a 4-fold decrease. This steep 
decline in foetal FAD under conditions of RCP im- 
munoneutralization points to basic similarities bet- 
ween biochemical events that manifest under con- 
ditions of immunoneutralization of the vitamin 
carrier and those precipitated by chronic flavin 
deficiency when the pregnant animals are fed 
either a riboflavin-deficient diet alone or that sup- 
plemented with galactoflavin [8]. In these earlier 
studies on maternal vitamin deficiency, both types 
of diets brought about comparable extents 
(30-37%) of total flavin deficiency, but galac- 
toflavin supplementation led to a 60% decline in 
FAD level [8]. Viewed from this angle, the above 
novel approach of producing selective foetal 
vitamin deficiency is far superior and quicker since 
decreases in total flavin (54%) and FAD (90%) 
were more severe. Interestingly, unlike under the 
conditions of hypothyroidism and dietary flavin 
deficiency in adult animals where hepatic concen- 
trations of FAD are maintained at the expense of 
the more dispensable FMN and free riboflavin [9], 
the contents of the latter two flavins are relatively 
less disturbed in the foetal tissue under conditions 
of immunoneutralization of maternal RCP. Fur- 
thermore, the flavin profile encountered in the af- 
fected foetuses is similar to that in hepatocytes 
during drug-induced carcinogenesis [lo], pointing 
to the basic similarities in flavin metabolism bet- 
ween the two types of rapidly proliferating cell 
types. 
Selective depletion of FAD in the affected foetus 
reflects itself in decreased activities of the two 
FAD dependent flavoenzymes (fig. 1) and is in con- 
formity with the above findings, although the ex- 
tents of decline in the two representative flavoen- 
zymes fall short of that expected from the 
magnitude of FAD depletion in the affected 
foetus; this may indicate that the enzyme-bound 
FAD represents a minor fraction of the total foetal 
FAD and has a slower turnover rate relative to 
total FAD. Of relevance in this context is that the 
t, of flavin coenzymes and the rate of exchange 
of free flavins with enzyme bound forms are 
known to be governed by the amount of free flavin 
available, the rate constants of association and 
dissociation and the presence of substrates and in- 
hibitors [ 1 I]. 
From the foregoing it is clear that the acute 
foetal flavin deficiency set&g in rapidly and 
severely as a consequence of immunological in- 
terference with maternal RCP brings about a 
drastic disturbance in flavin metabolism such that 
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vital metabolites like FAD fall to critically low 
levels; faced with this situation the rapidly pro- 
liferating foetus is presumably unable to cope with 
the enhanced demand for more flavin coenzymes 
for its growth and hence loses its viability. 
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